NM_001035.3:c.14091-25G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001035.3(RYR2):​c.14091-25G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 1,447,184 control chromosomes in the GnomAD database, including 121,790 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10781 hom., cov: 31)
Exomes 𝑓: 0.41 ( 111009 hom. )

Consequence

RYR2
NM_001035.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0840

Publications

6 publications found
Variant links:
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]
RYR2 Gene-Disease associations (from GenCC):
  • arrhythmogenic right ventricular dysplasia 2
    Inheritance: AD Classification: DEFINITIVE, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Ambry Genetics
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • catecholaminergic polymorphic ventricular tachycardia 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 1-237801831-G-A is Benign according to our data. Variant chr1-237801831-G-A is described in ClinVar as Benign. ClinVar VariationId is 257203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.623 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR2NM_001035.3 linkc.14091-25G>A intron_variant Intron 97 of 104 ENST00000366574.7 NP_001026.2 Q92736-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR2ENST00000366574.7 linkc.14091-25G>A intron_variant Intron 97 of 104 1 NM_001035.3 ENSP00000355533.2 Q92736-1
RYR2ENST00000661330.2 linkc.14109-25G>A intron_variant Intron 98 of 105 ENSP00000499393.2 A0A590UJF6
RYR2ENST00000609119.2 linkn.*5183-25G>A intron_variant Intron 96 of 103 5 ENSP00000499659.2 A0A590UK06

Frequencies

GnomAD3 genomes
AF:
0.367
AC:
54808
AN:
149540
Hom.:
10778
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.231
Gnomad AMI
AF:
0.374
Gnomad AMR
AF:
0.347
Gnomad ASJ
AF:
0.483
Gnomad EAS
AF:
0.641
Gnomad SAS
AF:
0.490
Gnomad FIN
AF:
0.406
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.407
Gnomad OTH
AF:
0.389
GnomAD2 exomes
AF:
0.413
AC:
93115
AN:
225654
AF XY:
0.418
show subpopulations
Gnomad AFR exome
AF:
0.215
Gnomad AMR exome
AF:
0.354
Gnomad ASJ exome
AF:
0.492
Gnomad EAS exome
AF:
0.622
Gnomad FIN exome
AF:
0.400
Gnomad NFE exome
AF:
0.403
Gnomad OTH exome
AF:
0.410
GnomAD4 exome
AF:
0.407
AC:
527615
AN:
1297538
Hom.:
111009
Cov.:
19
AF XY:
0.410
AC XY:
265680
AN XY:
648240
show subpopulations
African (AFR)
AF:
0.208
AC:
6356
AN:
30524
American (AMR)
AF:
0.357
AC:
15103
AN:
42274
Ashkenazi Jewish (ASJ)
AF:
0.494
AC:
11957
AN:
24198
East Asian (EAS)
AF:
0.643
AC:
24744
AN:
38460
South Asian (SAS)
AF:
0.477
AC:
37236
AN:
78062
European-Finnish (FIN)
AF:
0.398
AC:
17372
AN:
43608
Middle Eastern (MID)
AF:
0.487
AC:
2585
AN:
5306
European-Non Finnish (NFE)
AF:
0.397
AC:
389595
AN:
980772
Other (OTH)
AF:
0.417
AC:
22667
AN:
54334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
11903
23805
35708
47610
59513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12038
24076
36114
48152
60190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
54823
AN:
149646
Hom.:
10781
Cov.:
31
AF XY:
0.368
AC XY:
26930
AN XY:
73082
show subpopulations
African (AFR)
AF:
0.231
AC:
9166
AN:
39738
American (AMR)
AF:
0.348
AC:
5279
AN:
15184
Ashkenazi Jewish (ASJ)
AF:
0.483
AC:
1673
AN:
3466
East Asian (EAS)
AF:
0.641
AC:
3270
AN:
5100
South Asian (SAS)
AF:
0.491
AC:
2354
AN:
4790
European-Finnish (FIN)
AF:
0.406
AC:
4183
AN:
10308
Middle Eastern (MID)
AF:
0.473
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
0.407
AC:
27604
AN:
67766
Other (OTH)
AF:
0.390
AC:
815
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1670
3339
5009
6678
8348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.386
Hom.:
1749
Bravo
AF:
0.354
Asia WGS
AF:
0.495
AC:
1711
AN:
3452

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arrhythmogenic right ventricular dysplasia 2 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiac arrhythmia Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
4.4
DANN
Benign
0.48
PhyloP100
-0.084
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9428384; hg19: chr1-237965131; API